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Abstract
Background: Circulating cytokine patterns may be relevant for the diagnosis of asthma, for the discrimination of certain
phenotypes, and prognostic factors for exacerbation of disease.
Methodology/Principal Findings: In this study we investigated serum samples from 944 individuals of 218 asthma-affected
families by a multiplex, microsphere based system detecting at high sensitivity eleven asthma associated mediators: eotaxin
(CCL11), granulocyte macrophage stimulating factor (GM-CSF), interferon gamma (IFNc), interleukin-4 (IL-4), IL-5, IL-8, IL-10,
IL-12 (p40), IL-13, IL-17 and tumor necrosis factor alpha (TNFa). Single cytokine levels were largely similar between asthmatic
and healthy individuals when analysing asthma as single disease entity. Regulatory differences between parental and
pediatric asthma were reflected by six of the eleven mediators analyzed (eotaxin, IL-4, IL-5, IL-10, IL-12, TNFa). IL-12 (p40)
and IL-5 were the best predictor for extrinsic asthma in children with an increased odds ratio of 2.85 and 1.96 per log pg/ml
increase (IL-12 (p40): 1.2–6.8, p = 0.019, and IL-5: 1.2–2.5, p = 0.025). Frequent asthma attacks in children are associated with
elevated IL-5 serum levels (p = 0.013). Cytokine patterns seem to be individually balanced in both, healthy and diseased
adults and children, with various cytokines correlating among each other (IL-17 and IFNc (rs = 0.67), IL-4 and IL-5 (rs = 0.55),
IFNc and GM-CSF (rs = 0.54)).
Conclusion/Significance: Our data support mainly an age- but also an asthma phenotype-dependent systemic immune
regulation.
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Introduction
Asthma is the most common serious chronic lung disease and
shows increasing incidence in industrialized as well as in
developing countries, afflicting around 150 million people
worldwide [1]. With airway hyper-responsiveness being the
physiological hallmark of asthma, it is also characterized by
chronic inflammation of the respiratory tract, allergen-specific IgE
production, infiltration of eosinophils, the recruitment of T cells
into the airways, and alterations in the fine balance between type 1
helper T lymphocytes (Th1) and type 2 helper T lymphocytes
(Th2) responses towards Th2 bias [2].
Th2 cells secret a panel of cytokines with several overlapping
functions including Interleukin-4 (IL-4), IL-5, IL-13, and granu-
locyte-macrophage colony stimulating factor (GM-CSF). By
mediating differentiation of the Th2 subpopulation and eosino-
phils, as well as modulating B-cell proliferation and IgE switching,
the Th2 cytokines are thought to play a prominent role in asthma
[3,4]. The sentinel Th1 cytokine, interferon gamma (IFNc) and IL-
12 reciprocally stimulate their production and function during cell-
mediated immunity and development of naı¨ve T lymphocytes into
Th1 cells. Evidence suggests a contributory role of Th1 cells and
their cytokines in asthmatic inflammation and airway hyperre-
sponsiveness [5,6]. The T cell subset of regulatory T cells (Treg)
acts by expressing immunosuppressive cytokines, such as IL-10, of
which impaired production has been reported in asthmatic
patients [7]. Moreover, the lymphocyte lineage Th17 is increased
in inflamed airways [8] and characterised by the production of IL-
17. This pro-inflammatory cytokine is capable of causing the
release of other pro-inflammatory cytokines, such as IL-8, tumor
necrosis factor alpha (TNFa), and GM-CSF, which have been
associated with asthma in murine models [9], in humans [10,11],
or with disease severity [12,13,14,15].
Asthma – probably the most heterogeneous lung disease – may
also demonstrate systemic patterns outside the respiratory system.
Determination of serum cytokine levels in asthmatic patients could
have potential utility in diagnosis of asthma and certain phenotypes,
in prediction of attacks, and treatment choice. Although there are
numerous in vitro, as well as in vivo data from animal studies, to
date no information of large scale clinical studies exist that examines
a correlation between circulating cytokine levels and asthma
phenotypes or exacerbations of disease in different age groups.
Thus, the present study aimed at investigating circulating
cytokine and chemokine levels of healthy and asthmatic children
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as well as their parents. We hypothesized that one of the analyzed
cytokines and chemokines, or a combination is suited as a
serological marker for asthma or certain phenotypes. To test our
hypothesis we measured serum concentrations of eleven cytokines
and chemokines that were recently described to play an important
role in asthma pathogenesis: IL-4, IL-5, IL-8, IL-10, IL-12 (p40),
IL-13, IL-17, TNFa, GM-CSF, eotaxin, and IFNc.
Materials and Methods
Study Population
218 core families were selected during two study stages. The
sample is identical to previous reports [16,17,18] describing
explicitly the selection process, study participants and their clinical
characteristics. In the first stage, 97 families consisting of at least
two children with confirmed clinical asthma were selected for an
initial genome-wide linkage scan [18]. The families were collected
mainly in pediatric university clinical centers in Germany and
Sweden. At least two children with confirmed clinical asthma were
required, and prematurity or low birth weight of the children was
excluded, along with any severe pulmonary disease other than
asthma. In the second study stage, another set of asthma sib pair
families was selected. Three university hospitals and six pediatric
pulmonary practices carried out an identical phenotyping
procedure as during the first stage.
The 218 families comprised 944 individuals, of whom 424 were
parents with a mean age of 40 years and 499 were children with a
mean age of 11 years; 21 individuals had insufficient clinical
documentation and were excluded from further analysis. 275 of
the children were male, 224 were female and 443 had physician
diagnosed asthma. The youngest child diagnosed with asthma was
4 years old and the oldest child was 34 years old. Fifty-eight
percent of the children with asthma were boys. Asthma was
initially defined by clinical history and validated later by interview
questions. In addition to a clinical asthma diagnosis, all affected
children over age 3 had a history of at least 3 years of recurrent
wheezing and with no other airway diseases diagnosed.
The phenotyping procedure contained detailed interviews of
every family member, skin prick tests (SPT) of frequent allergens,
blood samples (for IgE and allergen-specific IgE (RAST)
measurements, eosinophil count), peak flow tests for a period of
10 days and dust collection at patients home. Total IgE was
determined with an ELISA (Pharmacia Diagnostics, Uppsala,
Sweden). SPT and RAST assays included several pollens, animal
furs, mould, and house dust mite allergens (ALK-SCHERAX,
Hamburg, Germany). Atopic (extrinsic) asthma was defined if
patients demonstrated at least one positive skin prick test reaction
or one increased specific IgE. Pulmonary function tests were
performed by forced flow volume tests and bronchial challenge
was done by a defined increasing methacholine exposure. Written
consent was given by all study participants. The parent/guardians
of all participants under 18 gave informed consent too. All study
methods were approved in 1995 by the Ethics Commission of
‘‘Nordrhein-Westfalen’’ and again in 2001 by ‘‘Bayerische Land-
esa¨rztekammer Mu¨nchen’’.
Cytokine Assays
Concentration of eotaxin, GM-CSF, IFN-c, IL-4, IL-5, IL-8,
IL-10, IL-12 (p40), IL-13, IL-17, TNF-a in the serum samples was
quantified using a custom-made MILLIPLEXTM MAP (multiple
analyte profile) Human Cytokine/Chemokine Panel (Millipore,
Schwalbach/Ts, Germany). The assay was performed according
to the recommendations of the manufacturer using a 8-point
standard curve for every cytokine. Samples were analyzed on a
Luminex 100 device (BioRad, Mu¨nchen, Germany) and the data
were evaluated using the Bio-Plex Manager software (BioRad).
Standards and internal controls were reported as means of
duplicate measurements. Samples were analyzed in single
measurements, since the MILLIPLEXTM MAP assay shows good
precision in pre-tests, with a stated intra-assay mean coefficient of
variance (CV) of 4.5% to 10.4%. The lower detection limits for
every cytokine and numbers of samples that were below the lower
detection limit and above the upper detection limit are listed in
Table S1 (online data supplement). Values below the detection
limit were set to the half of the detection limit and to 3000 pg/ml
if exceeding the maximum concentration of 3000 pg/ml.
Analysis
Statistical analyses were performed using R software. Following
a descriptive analysis using cross-tabulation and distribution of
single variables, linear and logistic regression analysis was used for
determination of effect estimates.
Results
The serum concentrations of the 11 cytokines and chemokines
IL-4, IL-5, IL-8, IL-10, IL-12 (p40), IL-13, IL-17, TNFa, GM-
CSF, Eotaxin, and IFNc could be obtained from 944 individuals
(Figure S1) from 218 families, of whom 424 were parents and 499
were children. Main demographic and clinical characteristics of
study participants were summarized in previous reports
[16,17,18]. In table 1 healthy and asthmatic parents are compared
as well as healthy and asthmatic children. Except of IL-8
(p = 0.012) and IL-10 (p = 0.045) in the adult group, none of the
cytokine concentrations in serum differ significantly between
healthy and diseased individuals. However, mean cytokine levels
for six of the eleven cytokines are significantly different between
asthmatic children and asthmatic adults. Values for Eotaxin
(p = 0.006), IL-10 (p = 0.002), and TNFa (p = 0.038) are higher in
parents than in children. In contrast IL-4 (p,0.001), IL-5
(p,0.001), and IL-12 (p40) (p = 0.001) serum levels are lower in
diseased adults compared to diseased children.
Results of serum cytokine measurements of the asthmatic
children and distinct clinical parameters were then further
analyzed in a regression model. In table 2 regression coefficients
and p-values are calculated using logarithmic values. Of the blood
cell counts, lymphocyte and eosinophil counts are inversely
associated to their cooperating chemokines (lymphocyte numbers
and IL-8: r =20.019, p = 0.011; eosinophil numbers and eotaxin:
r =20.432, p = 0.033). Furthermore IL-5 is positively associated
with eosinophilia (r = 0.119, p = 0.050), while IFNc/IL-5 demon-
strates an inverse association to eosinophil counts (r =20.119,
p = 0.030). Regression analysis of serum cytokine levels to
established clinical parameters of asthma, such as current lung
function (FEV1) and bronchial hyperreactivity (BHR), showed
weak results. Of all cytokines measured only the serum
concentrations of IL-4 (r = 0.016, p = 0.013), is associated with
the current lung function FEV1. However, in spite of a remarkable
result for IL-12 (p40) (p = 0.056), none of the eleven circulating
cytokines is related to BHR. But, classifying the number of asthma
attacks occurring in the last year to categories from one to four,
revealed that frequent asthma attacks in children are associated
with higher IL-5 serum levels (p = 0.013, Figure 1).
In table 3 the odds ratios (OR) are used to describe the
predictive value of serum cytokine levels to asthma subtypes,
allergic rhinitis, eczema, actual medication and hospitalization
frequency, while only asthmatic children were included in this
analysis. Atopic (extrinsic) asthma was defined if patients
Serum Cytokines in Asthma
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Table 1. Case control analysis of parents and children with and without asthma.
Cytokines descriptors
parents healthy
n=321
parents asthma
n=103
children healthy
n=56
children asthma
n=443
pediatric versus parental
asthma
eotaxin median [pg/ml] 117.2 105.3 92.1 88.2
iqr 80–164 73–150 72–116 65–121
P 0.141* 0.516** 0.006***
Bonf. P 1 1 0.072
GM-CSF median 73.5 82.8 121.6 77.0
iqr 25–228 25–290 29–334 29–202
P 0.699 0.167 0.620
Bonf. P 1 1 1
IFNc median 9.3 9.9 17.5 11.5
iqr 3–28 3–30 4–41 5–30
P 0.593 0.212 0.607
Bonf. P 1 1 1
IL-4 median 0.3 0.3 16.2 12.8
iqr 0–10 0–16 1–240 0–65
P 0.976 0.118 0.000
Bonf. P 1 1 0.000
IL-5 median 0.0 0.0 0.5 0.6
iqr 0–0 0–1 0–3 0–2
P 0.369 0.941 0.000
Bonf. P 1 1 0.000
IL-8 median 28.4 51.9 39.3 33.5
iqr 10–84 18–197 17–82 13–117
P 0.012 0.531 0.075
Bonf. P 0.144 1 0.900
IL-10 median 1.6 2.4 4.5 3.5
iqr 1–4 1–6 2–14 2–8
P 0.045 0.168 0.002
Bonf. P 0.54 1 0.024
IL-12(p40) median 22.5 9.0 59.7 42.0
iqr 5–64 5–63 7–123 5–108
P 0.833 0.447 0.001
Bonf. P 1 1 0.012
IL-13 median 0.2 0.2 3.4 1.0
iqr 0–5 0–8 0–8 0–6
P 0.816 0.063 0.275
Bonf. P 1 0.756 1
IL-17 median 9.1 10.7 12.1 7.8
iqr 2–28 2–30 3–33 2–26
P 0.934 0.165 0.737
Bonf. P 1 1 1
TNFa median 4.9 5.7 6.4 6.2
iqr 4–8 4–8 4–10 5–10
P 0.374 0.694 0.038
Bonf. P 1 1 0.456
*parental asthma vs no asthma,
**pediatric asthma vs no asthma,
***pediatric vs parental asthma.
Descriptors of cytokines and chemokines include the median serum concentration in pg/ml, the range of first and third quartile (iqr), the p-value in bold type (P), and
Bonferroni adjusted p-values in italics (Bonf. P) evaluated through non-parametric Wilcoxon test after log-transformation. Numbers of samples (n) of the respective
group are given in the upper row.
doi:10.1371/journal.pone.0014299.t001
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demonstrated at least one positive skin prick test reaction or one
increased specific IgE. IL-12 (p40) is the best predictor for extrinsic
asthma in children with an increased OR of 2.85 per log pg/ml
increase (1.19–6.84, p = 0.019) or vice versa with a decreased OR
of 0.35 (0.15–0.84, p = 0.019) for intrinsic asthma. Moreover
atopic and non-atopic asthma phenotypes were significantly
influenced by IL-5 levels (OR for atopic asthma 1.96 (1.09–3.52,
p = 0.025). A receiver operating characteristic (ROC) revealed a
sensitivity of 67.1% for IL-12 (p40) and 66.5% for IL-5 and
specificity of 66.7% for IL-12 (p40) and 58.3% for IL-5 serum
levels to distinguish between the extrinsic and intrinsic asthma
phenotype in children (Figure 2 A and B). The association of
serum cytokine levels to other atopic diseases, such as allergic
rhinitis and eczema, showed mixed results. For the latter no
circulating cytokine was predictive and for allergic rhinitis a strong
impact of IL-5 serum levels (OR: 1.42 (1.11–1.82), p = 0.005)
could be detected.
Generalized estimating equations of serum cytokine measure-
ments to clinical parameters as well as to atopic diseases,
medication, and hospitalization were carried out to adjust for
intra-cluster (intra-household) correlation (Table 4 and 5). In
Figure S2 (supplementary data) a regression analysis was carried
Table 2. Regression analysis of serum cytokines and clinical characteristics.
logarithmic
values
lymphocyte
counts
eosinophil
counts total IgE IgE for D1
IgE for
GX1
attack
frequency
asthma
onset FEV1 BHR
eotaxin 0.002 20.432 20.327 20.595 20.108 20.123 1.086 20.019 0.485
0.924 0.033 0.007 0.003 0.543 0.503 0.071 0.466 0.223
1 0.396 0.084 0.036 1 1 0.852 1 1
GM-CSF 0.002 0.039 0.037 0.031 0.027 20.034 0.211 20.011 20.106
0.813 0.549 0.322 0.623 0.632 0.546 0.260 0.221 0.411
1 1 1 1 1 1 1 1 1
IFNc 0.002 20.037 20.024 0.014 0.013 0.099 0.129 20.017 0.038
0.845 0.659 0.631 0.866 0.863 0.184 0.605 0.128 0.823
1 1 1 1 1 1 1 1 1
IL-4 20.005 20.006 0.049 0.038 0.017 0.035 0.131 0.016 20.014
0.282 0.907 0.076 0.404 0.671 0.395 0.354 0.013 0.892
1 1 0.912 1 1 1 1 0.156 1
IL-5 20.008 0.119 0.143 0.174 0.094 0.118 20.061 0.012 0.011
0.197 0.050 0.000 0.004 0.079 0.027 0.739 0.183 0.935
1 0.600 0.000 0.048 0.948 0.324 1 1 1
IL-8 20.019 0.093 0.042 20.064 0.150 20.149 0.384 0.016 0.231
0.011 0.212 0.338 0.377 0.019 0.022 0.076 0.335 0.365
0.132 1 1 1 0.228 0.264 0.912 1 1
IL-10 0.001 20.137 0.052 20.030 0.047 0.015 20.036 0.020 0.246
0.951 0.159 0.353 0.745 0.566 0.860 0.903 0.111 0.191
1 1 1 1 1 1 1 1 1
IL-12 (p40) 20.003 0.072 0.101 0.161 0.032 20.048 20.276 0.002 0.306
0.762 0.374 0.036 0.043 0.646 0.509 0.249 0.829 0.056
1 1 0.432 0.516 1 1 1 1 0.672
IL-13 0.008 20.038 0.001 20.040 20.008 0.002 20.014 0.001 20.002
0.150 0.474 0.981 0.438 0.857 0.964 0.930 0.908 0.989
1 1 1 1 1 1 1 1 1
IL-17 20.010 20.027 20.031 20.006 0.031 0.078 0.068 20.010 0.187
0.189 0.706 0.466 0.937 0.623 0.219 0.750 0.283 0.189
1 1 1 1 1 1 1 1 1
TNFa 20.020 0.116 20.058 20.215 0.023 20.218 0.875 20.036 0.684
0.253 0.500 0.569 0.243 0.888 0.154 0.086 0.180 0.091
1 1 1 1 1 1 1 1 1
IFNc/IL-5 0.006 20.119 20.133 20.129 20.079 20.035 20.010 20.018 0.011
0.311 0.030 0.000 0.016 0.097 0.475 0.953 0.014 0.922
1 0.360 0.000 0.192 1 1 1 0.168 1
Depicted are regression coefficients followed by p-values (in bold type) and Bonferroni adjusted p-values (in italics) calculated of the logarithmic values of the cytokines
and clinical parameters of asthmatic children (n = 443).
doi:10.1371/journal.pone.0014299.t002
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out to identify relations between cytokines. Positive correlations
could be found between IFNc and IL-17 levels (r = 0.67), within
the Th2 cytokines IL-4 and IL-5 (r = 0.55), and between IFNc and
GM-CSF (r = 0.54). The division into healthy and asthmatic
individuals resulted in similar correlation patterns (data not
shown). Figure S3 (supplementary data) shows a principal
component analysis of cytokine concentrations.
Discussion
In adults and children affected with asthma, several pathophys-
iological effects have been associated with imbalanced T cell
activation and the presence or absence of distinct immune
mediators. Thus cytokines and chemokines evoke increasing interest
for diagnosis and therapy. The present study aimed at understand-
ing the pattern of circulating cytokines in asthmatic adults and
children. To assess the potential value of serum cytokines as
biomarker for asthma, or certain asthma phenotypes, or prediction
of exacerbation of disease, we compared serum levels of eleven
distinct asthma associated mediators of 218 families where at least
two children have asthma. A number of authors have studied serum
cytokines in asthmatic patients [15,19,20,21,22,23]. However, no
study covered such a large set of individuals with inclusion of a large
number of cytokines and chemokines.
The results presented here concern asthmatic and healthy
siblings and their parents and provide reference values for serum
cytokine levels of asthma families and the respective age group.
Like in measurements of a similar design, the results demonstrate a
high variability of serum cytokine amounts between individuals
[24] and at the same time, reveal distinct characteristics in the
distributions of the single cytokines and chemokines analyzed
(Figure S1). No differences were observed between healthy and
diseased individuals in the cytokines analyzed, except IL-8 in
adults (table 1). In this analysis asthma was referred to as one
disease and was not divided into distinct subgroups. Our data
differ from those of the exploratory study of ten Hacken et al. who
found that the median levels of serum IL-4, IL-5, and IFNc were
significantly higher in asthmatic patients than in healthy controls
[25]. Instead, our results support the hypothesis of asthma not
being associated with changes of serum cytokine amounts, when
regarded as single disease entity. A most likely explanation could
be that asthma is a complex and heterogeneous disease consisting
of many phenotypes [1]. On the contrary, it might be that systemic
patterns of Th1-, Th2-, Th17-, and Treg -cytokines in serum do not
reflect the same immune imbalances proposed for the diseased
organs of immune mediated disorders. In this respect, it has been
suggested, that findings concerning inflammatory mediators of
asthmatic patients differ in serum and bronchial lavage fluid [19].
Figure 1. Box plot of serum IL-5 concentrations and asthma attack rates in one year. Only asthmatic children (n = 443) were included in
this analysis. The numbers of asthma attacks occurring in the last year were classified into continuous categories from one to four. Numbers of
samples of the respective groups are 213 (group 1), 175 (group 2), 26 (group 3), and 29 (group 4). Children with the most frequent asthma attacks
had the highest serum levels of IL-5 (p = 0.013).
doi:10.1371/journal.pone.0014299.g001
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Additionally, frequencies of cytokine producing T cells in blood do
not reflect those in sputum [26]. It should be mentioned that the
study design of the German Asthma Family Study may not be
advantageous for comparing healthy and diseased children, due to
a small proportion of healthy children (n= 56), resulting in a loss of
power to discriminate between health and disease. However, since
the healthy children are sharing genes and environment with the
asthmatic children, the discordance for disease may be of
particular interest, even with low nominal power.
Serum cytokine patterns showed marked differences between
parental and pediatric asthma. In asthmatic children cytokine
levels demonstrated significant elevation in IL-4, IL-5, and IL-
12(p40), and a decrease in eotaxin, IL-10, and TNFa, compared to
asthmatic adults (table 1). This points at age being important
factors in systemic immune regulation of asthma. The impact of
age was also recently shown for mitogen-stimulated cytokine
production in a general population [27]. Further, our data and
literature data point at the importance of evaluating circulating
cytokine levels in specific asthma phenotypes. Wong et al. found
higher plasma concentrations of IL-18, IL-12, IL-10, and IL-13 in
allergic asthmatic patients than in healthy controls [28]. Silvestri et
al. stated that, IL-8 and TNFa, but not IL-16 and IL-13, serum
levels were higher in severe asthmatic compared to mild-moderate
asthmatics or controls [15]. Our study includes mainly individuals
Table 3. Predictive value of serum cytokine levels for extrinsic asthma, allergic rhinitis, eczema, actual medication and
hospitalization frequency.
log. values extrinsic asthma allergic rhinits eczema steroid use hospitalization
eotaxin 0.38 (0.03–4.19) 1.88 (0.81–4.36) 0.41 (0.14–1.25) 0.35 (0.12–1.02) 0.50 (0.20–1.24)
0.426 0.143 0.116 0.054 0.136
1 1 1 0.648 1
GM-CSF 1.08 (0.55–2.09) 1.20 (0.93–1.55) 1.20 (0.88–1.65) 0.85 (0.63–1.15) 0.86 (0.66–1.12)
0.827 0.169 0.254 0.299 0.254
1 1 1 1 1
IFNc 0.55 (0.23–1.35) 1.32 (0.95–1.85) 1.20 (0.79–1.82) 0.70 (0.47–1.05) 1.01 (0.71–1.42)
0.194 0.099 0.401 0.083 0.974
1 1 1 0.996 1
IL-4 1.46 (0.92–2.33) 1.20 (0.99–1.45) 1.15 (0.91–1.47) 0.93 (0.75–1.15) 0.95 (0.79–1.16)
0.107 0.059 0.238 0.506 0.632
1 0.708 1 1 1
IL-5 1.96 (1.09–3.52) 1.42 (1.11–1.82) 1.16 (0.85–1.60) 1.10 (0.85–1.44) 0.87 (0.68–1.10)
0.025 0.005 0.354 0.473 0.245
0.300 0.060 1 1 1
IL-8 0.95 (0.47–1.92) 1.29 (0.95–1.74) 1.13 (0.76–1.70) 1.10 (0.79–1.55) 0.81 (0.59–1.10)
0.891 0.098 0.544 0.563 0.180
1 1 1 1 1
IL-10 1.66 (0.64–4.26) 0.95 (0.65–1.40) 1.18 (0.71–1.97) 1.43 (0.93–2.21) 0.82 (0.55–1.22)
0.295 0.805 0.522 0.107 0.319
1 1 1 1 1
IL-12(p40) 2.85 (1.19–6.84) 1.11 (0.80–1.54) 0.91 (0.60–1.40) 0.92 (0.64–1.33) 1.00 (0.72–1.40)
0.019 0.525 0.681 0.660 0.990
0.228 1 1 1 1
IL-13 0.87 (0.50–1.52) 1.11 (0.90–1.37) 1.12 (0.85–1.49) 0.93 (0.73–1.17) 0.80 (0.64–1.00)
0.622 0.347 0.421 0.528 0.050
1 1 1 1 0.600
IL-17 0.63 (0.30–1.33) 1.24 (0.93–1.66) 0.95 (0.66–1.37) 0.87 (0.63–1.21) 1.00 (0.74–1.34)
0.226 0.137 0.803 0.416 0.988
1 1 1 1 1
TNFa 1.82 (0.25–13.14) 1.00 (0.50–2.00) 1.15 (0.44–3.05) 1.49 (0.65–3.41) 0.66 (0.31–1.42)
0.554 0.775 0.346 0.293 0.293
1 1 1 1 1
IFNc/IL-5 0.36 (0.19–0.70) 0.84 (0.67–1.05) 0.93 (0.71–1.23) 0.76 (0.59–0.98) 1.15 (0.92–1.44)
0.003 0.120 0.627 0.035 0.234
0.036 1 1 0.420 1
Only asthmatic children (n = 443) were included in this analysis. Depicted are odds ratios followed by p-values (in bold type), and Bonferroni adjusted p-values (in italics).
doi:10.1371/journal.pone.0014299.t003
Serum Cytokines in Asthma
PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e14299
Serum Cytokines in Asthma
PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e14299
from university hospitals and families with two affected children.
To control for correlation across family members generalized
estimating equations of serum cytokine measurements to clinical
parameters as well as to atopic diseases, medication, and
hospitalization were carried (Table 4 and 5). Nevertheless, the
study design certainly leads to a biased sample towards children
with a strong familiar/genetic component and towards children
with more severe disease. But, more extreme phenotypes may be
more informative for detecting any biochemical or genetic
abnormalities.
The most common classification of asthma is the division into
extrinsic (atopic, allergic) and intrinsic (non-allergic) phenotype.
The finding that systemic levels of IL-12 (p40), IL-5, and IFNc/IL-
5 reflect the regulatory differences between the allergic and non-
allergic pediatric asthma subgroups (table 3), led us to address this
issue more closely. The expression of IL-12, a heteromeric protein
consisting of the two subunits p35 and p40, and the monomeric
and homodimeric form of p40 respectively, has proven to be
associated with asthma [5]. Furthermore, anti-IL-12-p35 or anti-
IL-12-p40 monoclonal antibodies were shown to abolish asthma
symptoms during the challenge phase in a mouse model of
experimental asthma [29]. In contrast to IL-12, a substantial body
of data in mice and humans support the importance of IL-5 in
asthma [3,30]. Frequent asthma attacks were significantly
associated with higher circulating IL-5 levels (Figure 2). To
determine, if any of the analyzed serum cytokine levels could be
used as a potential disease indicator, the diagnostic value of IL-12
(p40) and IL-5 were directly tested in a receiver operating
characteristic (Figure 2A, B). IL-12 and IL-5 demonstrate only
moderate marker characteristics to distinguish between the
extrinsic and intrinsic asthma phenotype. The clinical use of these
cytokines is still hampered by the fact that there would be too high
false negatives and positives.
In the present study serum cytokine levels and its correlations to
clinical symptoms, such as blood cell count, total and specific IgE,
asthma onset, and pulmonary function was evaluated to assess
practical applicability (table 2). Overall correlating circulating
cytokine concentrations to established clinical parameters of
asthma did not reveal any clear pattern. Our results may indicate
that serum cytokine levels and functional tests reflect distinct
aspects of the pathophysiology of asthma, and clinical symptoms
occur independently of systemic cytokine levels. However, this
contrasts with results of Nakamura et al. who found that plasma
eotaxin levels were inversely related to percent predicted FEV1
and directly related to asthma diagnosis in a large population [22].
Unlike results of some exploratory studies [21,25,31,32], in our
Table 4. Generalized estimating equations of serum cytokines and clinical characteristics.
logarithmic
values
lymphocyte
counts
eosinophil
counts
neutrophil
counts total IgE
IgE for
D1
IgE for
GX1
attack
frequency
asthma
onset FEV1 BHR
eotaxin 0,022 20,338 0,280 20,182 20,419 20,216 20,121 0,855 20,005 0,015
0,078 0,035 0,875 0,087 0,000 0,043 0,403 0,055 0,736 0,956
GM-CSF 20,001 0,022 0,259 0,024 20,015 0,030 0,015 0,225 20,004 20,103
0,757 0,667 0,596 0,343 0,696 0,418 0,757 0,105 0,516 0,231
IFNc 0,004 20,083 20,049 20,010 20,024 0,038 0,128 20,032 0,003 20,029
0,548 0,128 0,939 0,776 0,572 0,356 0,035 0,849 0,627 0,810
IL-4 20,009 20,063 0,478 0,013 20,017 0,025 0,044 20,043 0,004 20,058
0,031 0,125 0,258 0,521 0,567 0,356 0,280 0,706 0,409 0,386
IL-5 20,010 20,025 0,477 0,093 0,096 0,037 0,124 20,165 20,002 20,048
0,035 0,703 0,378 0,001 0,016 0,324 0,006 0,271 0,816 0,593
IL-8 20,024 0,090 0,441 0,033 20,045 0,147 20,138 0,400 0,016 0,179
0,000 0,237 0,630 0,330 0,371 0,005 0,017 0,029 0,211 0,326
IL-10 20,008 0,024 0,206 0,045 20,020 0,037 0,056 20,126 0,004 0,035
0,206 0,736 0,768 0,204 0,641 0,464 0,366 0,555 0,602 0,723
IL-12 (p40) 20,006 20,025 0,478 0,028 0,066 20,002 0,021 0,005 20,003 0,152
0,328 0,711 0,436 0,436 0,130 0,956 0,732 0,983 0,690 0,111
IL-13 0,002 20,017 20,330 0,004 20,047 20,010 0,016 20,108 0,004 20,030
0,589 0,695 0,522 0,870 0,116 0,748 0,694 0,338 0,607 0,700
IL-17 20,007 20,082 0,575 20,015 20,023 0,047 0,089 20,125 0,005 0,033
0,147 0,172 0,225 0,628 0,599 0,257 0,082 0,446 0,425 0,714
TNFa 20,010 0,151 21,179 20,081 20,160 20,073 20,182 0,760 20,024 0,291
0,423 0,233 0,401 0,324 0,091 0,524 0,076 0,032 0,159 0,163
Depicted are regression coefficients followed by p-values (in bold type) calculated of the logarithmic values of the cytokines and clinical parameters of asthmatic
children (n = 443).
doi:10.1371/journal.pone.0014299.t004
Figure 2. Receiver operating characteristic for the diagnostic value of IL-12 (p40) (A) and IL-5 (B). Only asthmatic children (n = 443) were
included in this analysis. Area under the curve of the ROC plot produced a sensitivity of 67.1% and specificity of 66.7% for IL-12(p40), and a sensitivity
of 66.5% and a specificity of 58.3% for IL-5 to distinguish between the extrinsic and intrinsic asthma phenotype.
doi:10.1371/journal.pone.0014299.g002
Serum Cytokines in Asthma
PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e14299
study asthmatic children did not demonstrate an association of
serum IFNc to clinical manifestations of asthma, possibly due to
distinct study designs and inclusion criteria for the selection of
cases, again outlining the crucial role of subdividing asthma into
defined phenotypes.
IL-8 is a pro-neutrophilic chemokine that is secreted by various
cell types. For more than 10 years, IL-8 has been suggested to play
an important role in asthma, and especially in severity of disease
[11,13,15]. In our study, analysing IL-8 serum levels in regard to
clinical parameters of asthma, demonstrated several significant
results. It correlated negatively with lymphocyte counts, asthma
attack frequency and positively with specific IgE for GX1 (table 2)
and, additionally, IL-8 serum concentrations differed between
healthy and asthmatic adults (table 1). This points towards an
important systemic role for IL-8. However, our analysis was
hampered by the observation that IL-8 levels of the first funding
period, which took place from 1995 to 1998, were markedly lower
than IL-8 concentrations of the second part of the study, which
took place from 2000 to 2001. This contrasts with the homogenous
measurements for the other analyzed cytokines (Figure S1). Due to
the fact that all cytokines were quantified in one assay and
originate of the same serum sample, which was thawed only once,
we can largely exclude laboratory procedures to be responsible for
this phenomenon. The only difference between samples of the first
study and the second study half is the time of storage at 280uC
(14-11 years versus 9-8 years). IL-8 may be the most unstable of
the analyzed cytokines, which is supported by the conclusion of
Friebe et al., who recently proposed that there are major
differences in the stability of cytokines in blood samples [33].
For a better understanding of the regulation of cytokine
networks in asthmatic patients, we considered further the
possibility of a direct or inverse relationship between Th2, Th1,
Treg and Th17 cytokines. Pair wise assessment of correlations
among the analyzed cytokines, revealed a strong positive
correlation between IFNc and IL-17 within healthy and asthmatic
individuals (Figure S2). This is in accordance with previous data
where elevation of the dominant Th1 cytokine IFNc and the
strong pro-inflammatory cytokine IL-17, have been reported in
sputum of asthmatic patients [26,34]. It is obvious in our analysis
that the cytokines are correlated in healthy controls and asthmatic
patients. Based on the knowledge that IFNc, has generally been
considered having a negative role on Th17 cell differentiation and
expansion [35], this direct relation could be due to an individually
balanced cytokine pattern. This is favored also by a direct relation
for the Th2 cytokines IL-4 and IL-5, and IFNc and GM-CSF. The
hypothesis of a relative balance appearing more important than
actual concentrations was suggested also recently by Halonen et al.
for cytokine production in mothers, fathers, and infants of a large
birth cohort [27].
Our data do not provide information about the origin of the
analyzed cytokines. It is known that during allergic reactions, no
activated lymphocytes are found in the circulation, although there
is an increase in local lymphocyte activity [36]. Such factors would
favor the importance of the local environment, such as lung tissue,
to search for a marker of practical applicability, but less invasive
measures, such as serum, represent the great advantage of being
much easier to obtain, especially in children. Considering the
inconclusive overall pattern in obtaining biomarker characteristics
Table 5. Generalized estimating equations of serum cytokine levels and extrinsic asthma, allergic rhinitis, eczema, actual
medication and hospitalization frequency.
log. values extrinsic asthma allergic rhinits eczema steroid use hospitalization
eotaxin 0,98 (0,94–1,02) 0,98 (0,86–1,11) 0,93 (0,81–1,07) 0,90 (0,79–1,03) 0,93 (0,80–1,08)
0,352 0,694 0,323 0,134 0,358
GM-CSF 1,01(0,99–1,04) 1,02(0,99–1,06) 1,04(1,00–1,08) 0,99(0,94–1,03) 0,97(0,93–1,02)
0,372 0,230 0,082 0,557 0,279
IFNc 0,99(0,96–1,03) 1,05(1,00–1,10) 1,05(0,99–1,11) 0,95(0,90–1,01) 0,98(0,92–1,05)
0,724 0,040 0,113 0,112 0,582
IL-4 1,01(1,00–1,03) 1,04(1,01–1,07) 1,01(0,97–1,05) 1,00(0,97–1,04) 0,99(0,96–1,02)
0,116 0,016 0,598 0,928 0,343
IL-5 1,02(1,00–1,04) 1,07(1,03–1,11) 1,01(0,96–1,07) 1,01(0,97–1,06) 0,97(0,92–1,01)
0,022 0,001 0,681 0,486 0,145
IL-8 0,99(0,97–1,02) 1,03(0,98–1,08) 1,04(0,97–1,12) 1,01(0,95–1,06) 0,97(0,91–1,02)
0,673 0,280 0,263 0,832 0,250
IL-10 1,02(0,99–1,05) 1,05(0,99–1,10) 1,04(0,97–1,12) 1,06(1,00–1,13) 0,98(0,92–1,04)
0,221 0,085 0,233 0,065 0,444
IL-12(p40) 1,03(1,00–1,05) 1,01(0,96–1,07) 1,00(0,93–1,06) 0,99(0,94–1,05) 1,00(0,94–1,06)
0,076 0,624 0,906 0,819 0,901
IL-13 1,01(0,99–1,02) 1,03(0,99–1,06) 1,01(0,97–1,05) 1,00(0,96–1,03) 0,97(0,93–1,01)
0,598 0,099 0,648 0,898 0,099
IL-17 1,00(0,97–1,02) 1,05(1,00–1,10) 1,04(0,99–1,10) 0,98(0,92–1,03) 1,00(0,95–1,05)
0,815 0,029 0,118 0,379 0,947
TNFa 0,99(0,94–1,03) 0,92(0,82–1,03) 1,08(0,92–1,27) 1,05(0,94–1,16) 0,93(0,84–1,03)
0,545 0,144 0,365 0,403 0,156
Depicted are odds ratios followed by p-value (in bold type). Only asthmatic children (n = 443) were included in this analysis.
doi:10.1371/journal.pone.0014299.t005
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for any of the analyzed cytokines, our data do not support the idea
of a routine evaluation of serum cytokines in asthmatic patients
and point at the importance of precisely defining asthma subtypes.
Little is known about the dynamics of circulating cytokines,
including degradation, regulation and half life, which was not
addressed in this study and remain to be elucidated in further
studies. This knowledge would pave the way for a conclusive
interpretation and validation of systemic immune mediators and
the discovery of a serological marker for asthma or asthma
phenotypes or severity respectively.
In conclusion, the present study demonstrates main character-
istics of serum cytokine patterns in healthy and asthmatic children
and adults, and provides for the first time reference values for these
groups in a large population. Serum patterns were not different
between healthy and asthmatic individuals, with regard to absolute
amounts. By looking at distinct phenotypes of asthma, patterns of
circulating immune mediators demonstrated major differences.
Serum levels of six out of eleven mediators analyzed differed in
parental and pediatric asthma. IL-12 (p40), IL-5, and IFNc/IL-5
showed differences between the extrinsic and intrinsic asthma
phenotype. High IL-5 serum levels are associated with frequent
asthma attacks in children. Furthermore, cytokine patterns seem to
be individually balanced both in healthy and diseased adults and
children. The precise mechanism of how systemic cytokines and
their coactive interactions might be involved in driving asthma
processes, however, remains elusive. A further expansion of
the cytokine panel tested, possibly coupled even with direct
local measurements and clearly defined asthma phenotypes is
warranted.
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Table S1 Assay Sensitivities of MILLIPLEX MAP for the 11
analyzed Cytokines and Chemokines.
Found at: doi:10.1371/journal.pone.0014299.s001 (0.05 MB
DOC)
Figure S1 Histogram of serum cytokine levels of all individuals.
Each of the cytokines has its own scale and concentrations are in
the range of pg/ml. The 944 study participants are ordered
chronologically by the time of examination (on the x axis). There is
a high variability of serum cytokine amounts between individuals.
One individual showed extremely high levels at nearly all
cytokines. Single cytokines demonstrate distinct characteristics in
their distributions.
Found at: doi:10.1371/journal.pone.0014299.s002 (0.38 MB TIF)
Figure S2 Correlation matrix of the analyzed cytokine concen-
trations. Pair wise assessment of correlations, revealed a strong
positive relation for IL-17 and IFNc levels (rs = 0.67), GM-CSF
and IFNc levels (rs = 0.54), as well as IL-4 and IL-5 (rs = 0.55).
Found at: doi:10.1371/journal.pone.0014299.s003 (2.55 MB TIF)
Figure S3 Principal component analysis of serum cytokine
concentrations.
Found at: doi:10.1371/journal.pone.0014299.s004 (0.13 MB TIF)
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